Markets:

Overview

News

Currencies

International

Treasuries

Rigel Pharmaceuticals, Inc. - Common Stock (NQ:RIGL)

26.65 +0.10 (+0.38%)

Streaming Delayed Price Updated: 10:00 AM EDT, Mar 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Rigel Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Stock Market Today, March 16: CytomX Therapeutics Surges After Positive Phase 1 Colorectal Cancer Data ↗

March 16, 2026

Today, March 16, 2026, investors weigh striking early colorectal cancer results against weak quarterly numbers and a finite cash runway.

Via The Motley Fool

Topics Stocks

Rigel Pharma (RIGL) Earnings Call Transcript ↗

March 03, 2026

Rigel Pharma (RIGL) Earnings Call Transcript

Via The Motley Fool

Topics Earnings

RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL): A GARP Stock with Affordable Growth and Strong Fundamentals ↗

January 21, 2026

Via Chartmill

Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Shows Strong Growth and Technical Momentum ↗

December 31, 2025

Via Chartmill

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Presents a Compelling Case for Value Investors ↗

October 27, 2025

Via Chartmill

Rigel Pharmaceuticals Inc. (NASDAQ:RIGL) Emerges as a Top Affordable Growth Stock ↗

December 16, 2025

Rigel Pharmaceuticals (RIGL) presents a strong GARP investment case with high growth, solid profitability, and a notably low valuation compared to its biotech peers.

Via Chartmill

RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL) Presents a Strong 'Decent Value' Investment Case ↗

December 13, 2025

Rigel Pharmaceuticals (RIGL) presents a strong value investment case with a very low P/E ratio, robust financial health, and high earnings growth potential.

Via Chartmill

RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL) Meets Minervini Trend Template and High-Growth Momentum Criteria ↗

December 02, 2025

Rigel Pharmaceuticals (RIGL) aligns with Mark Minervini's growth strategy, showing a strong technical uptrend supported by accelerating earnings and revenue momentum.

Via Chartmill

RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL): A GARP Investment with Strong Growth and a Reasonable Price ↗

November 24, 2025

Discover Rigel Pharmaceuticals (RIGL), a GARP stock with explosive growth, a low P/E ratio, and strong financials, offering value in the biotech sector.

Via Chartmill

Keep an eye on the top gainers and losers in Wednesday's session. ↗

November 05, 2025

Curious to know what's happening on the US markets in the middle of the day on Wednesday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 05, 2025

Via Benzinga

Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday ↗

November 05, 2025

Via Benzinga

Wednesday's session: gap up and gap down stocks ↗

November 05, 2025

Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

These stocks that are showing activity before the opening bell on Wednesday. ↗

November 05, 2025

The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 05, 2025

Via Benzinga

Why Teradata Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket ↗

November 05, 2025

Via Benzinga

What's going on in today's after hours session ↗

November 04, 2025

Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 04, 2025

Via Benzinga

A Look Ahead: Rigel Pharmaceuticals's Earnings Forecast ↗

November 03, 2025

Via Benzinga

Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Shows Strong Alignment with Navellier's Growth Criteria ↗

October 29, 2025

Rigel Pharmaceuticals shows explosive growth, strong cash flow, and high ROE, aligning with Louis Navellier's proven stock-picking system for growth investors.

Via Chartmill

RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL) Combines Strong Growth and Bullish Technicals ↗

October 21, 2025

RIGL stock shows strong revenue & earnings growth with a low P/E ratio. Its technical chart pattern suggests a potential breakout from a recent trading range.

Via Chartmill

Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Embodies the 'Affordable Growth' Investment Strategy ↗

October 17, 2025

Rigel Pharmaceuticals offers strong growth and earnings at an affordable valuation, making it a compelling candidate for the "Affordable Growth" investment strategy.

Via Chartmill

RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL) Stands Out as a Top Growth Stock Candidate ↗

October 08, 2025

RIGL stock shows explosive growth with 5,567% EPS surge, soaring sales, and strong earnings surprises, fitting a proven growth investing model.

Via Chartmill

Rigel Pharmaceuticals Inc (NASDAQ:RIGL): An Affordable Growth Stock with Strong Upside Potential ↗

September 25, 2025

Rigel Pharmaceuticals (RIGL) offers high growth with a low P/E ratio. Strong EPS & revenue growth meet an affordable valuation, fitting the "affordable growth" investment profile.

Via Chartmill

Freeport-McMoRan, Harmony Biosciences, Cohu, And Other Big Stocks Moving Lower On Wednesday ↗

September 24, 2025

Via Benzinga

Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Identified as a Top Value Stock with Strong Fundamentals ↗

September 23, 2025

Rigel Pharmaceuticals (RIGL) is a biotech stock with a compelling valuation, trading at a low P/E ratio. It boasts strong profitability, exceptional revenue & EPS growth, and solid financial health.

Via Chartmill

Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Shows Explosive Growth, Fits Navellier's 'Little Book' Strategy ↗

September 16, 2025

Rigel Pharmaceuticals shows explosive growth with 729% EPS growth, 106% revenue surge, and a 119% ROE, making it a top pick for momentum investors.

Via Chartmill

RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL) Combines High Growth Momentum with Strong Technical Setup ↗

September 09, 2025

Discover RIGL stock's high growth momentum & strong technical setup. A top pick for investors seeking earnings acceleration & breakout potential.

Via Chartmill

Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Emerges as a Top Affordable Growth Stock ↗

September 03, 2025

Rigel Pharmaceuticals (RIGL) is a GARP stock with explosive 729% EPS growth, trading at a deep discount with a P/E of just 7.11.

Via Chartmill

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.